We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

115 hedge funds and large institutions have $161M invested in VanEck Biotech ETF in 2023 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 28 increasing their positions, 32 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.4% more ownership

Funds ownership: 31.43% → 32.83% (+1.4%)

3% more capital invested

Capital invested by funds: $156M → $161M (+$5.16M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less funds holding

Funds holding: 120 → 115 (-5)

13% less repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 32

14% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 14

Holders
115
Holders Change
-5
Holders Change %
-4.17%
% of All Funds
1.83%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
28
Reduced
32
Closed
14
Calls
$292K
Puts
–
Net Calls
+$292K
Net Calls Change
-$140K

Top Buyers

Rank Fund Capital Flow
1
MIM
Miller Investment Management
Pennsylvania
+$16.3M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$1.72M
3
Envestnet Asset Management
Envestnet Asset Management
Illinois
+$1.08M
4
Bank of America
Bank of America
North Carolina
+$1M
5
Citadel Advisors
Citadel Advisors
Florida
+$994K

Top Sellers

Rank Fund Capital Flow
1
KAS
Kestra Advisory Services
Texas
-$2.58M
2
LJAC
L.J. Altfest & Co
New York
-$2.28M
3
JP Morgan Chase
JP Morgan Chase
New York
-$2.08M
4
TAM
Tocqueville Asset Management
New York
-$1.97M
5
BIM
Bullseye Investment Management
Ohio
-$1.78M
Name Holding Trade Value Shares
Change 		Change in
Stake
National Bank of Canada
101
National Bank of Canada
Quebec, Canada
$12.1K – – –
IA
102
IFP Advisors
Florida
$12.1K -$208K -1,283 -93%
HCM
103
Hollencrest Capital Management
California
$11.3K – – –
NA
104
NewEdge Advisors
Louisiana
$9.44K +$2.1K +13 +29%
BAM
105
Belpointe Asset Management
Nevada
$7.62K – – –
HI
106
Harbour Investments
Wisconsin
$7.13K – – –
GFPC
107
Global Financial Private Client
Florida
$7.13K – – –
TWC
108
TD Waterhouse Canada
Ontario, Canada
$4.86K +$4.85K +30 New
AIP
109
Ameritas Investment Partners
Nebraska
$4.86K – – –
PP
110
Pacifica Partners
Canada
$4.11K – – –
VanEck Associates
111
VanEck Associates
New York
$3K +$324 +2 +11%
Commonwealth Equity Services
112
Commonwealth Equity Services
Massachusetts
$2.76K -$49.7K -307 -2%
CFGS
113
Concourse Financial Group Securities
Alabama
$1.78K -$1.62K -10 -48%
SPIA
114
Steward Partners Investment Advisory
New York
$1.14K -$1.13K -7 -50%
BHWM
115
Beaird Harris Wealth Management
Texas
$1.14K – – –
TAM
116
Tocqueville Asset Management
New York
– -$1.97M -12,319 Closed
BIM
117
Bullseye Investment Management
Ohio
– -$1.78M -11,147 Closed
Chevy Chase Trust
118
Chevy Chase Trust
Maryland
– -$1.4M -8,741 Closed
IAMOG
119
Investors Asset Management of Georgia
Georgia
– -$383K -2,400 Closed
SPM
120
Symmetry Peak Management
Pennsylvania
– -$351K -2,200 Closed
HWM
121
Howard Wealth Management
Connecticut
– -$223K -1,398 Closed
HFAS
122
Hummer Financial Advisory Services
Illinois
– -$217K -1,360 Closed
JIP
123
Jaffetilchin Investment Partners
Florida
– -$207K -1,294 Closed
CAL
124
Capital Analysts LLC
Pennsylvania
– -$65K -406 Closed
USCWA
125
U.S. Capital Wealth Advisors
Texas
– -$59.9K -375 Closed
2 3 4
5
6

BBH Hedge Fund Activity: Q1 2023 in Review

115 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q1 2023, worth a combined $161M — up 3.3% from $156M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of BBH and 12 opened new positions — a net loss of 2 holders — while 32 trimmed existing stakes and 28 added.

The largest buyer was Miller Investment Management, adding an estimated $16.3M. The largest seller was Kestra Advisory Services, cutting an estimated $2.58M.

  • 115 institutional investors held VanEck Biotech ETF (BBH) as of Q1 2023, down from 120 in Q4 2022.
  • Funds reported $161M of VanEck Biotech ETF stock for Q1 2023, up 3.3% quarter-over-quarter.
  • 12 funds opened new VanEck Biotech ETF positions in Q1 2023 and 14 closed out, a net change of -2 holders.
  • The largest VanEck Biotech ETF buyer in Q1 2023 was Miller Investment Management, an estimated $16.3M added.
  • The largest VanEck Biotech ETF seller in Q1 2023 was Kestra Advisory Services, an estimated $2.58M sold.

Based on aggregated 13F filings for Q1 2023.